We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

USPTO: Arthrex review needed to end ‘constitutional infirmity’

Intellectual Property Magazine

USPTO: Arthrex review needed to end ‘constitutional infirmity’

The US Patent and Trademark Office (USPTO) has asked the Supreme Court of the US (SCOTUS) to review the controversial US Court of Appeals for the Federal Circuit (CAFC) Arthrex Inc v Smith & Nephew Inc decision and postpone granting any similar appeals until the case is resolved.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer

Not yet an i-law subscriber?


Request a trial Find out more